Literature DB >> 3135009

Impaired renal functional reserve and albuminuria in essential hypertension.

A Losito1, F Fortunati, I Zampi, A Del Favero.   

Abstract

The stimulatory effects of an infusion of amino acids on glomerular filtration rate has previously been used to measure renal functional reserve and detect glomerular hyperfiltration. Thirty four patients with mild to moderate essential hypertension and seemingly normal renal function and 22 healthy controls were given infusions of amino acids to investigate whether renal functional reserve is reduced in essential hypertension and to detect patients at risk of renal damage. Although basal creatinine clearance increased after the infusion of amino acids in the controls (mean 27.9 ml/min; 95% confidence interval 18.2 to 37.6), the overall change was lower in the patients (mean 13.4 ml/min; 8.3 to 18.5), 11 of the 34 showing no increase at all. In these 11 non-responders the mean systolic blood pressure was higher than that in the 23 others (178.5 mmHg v 157 mmHg, respectively). Mean urinary albumin excretion was abnormal in the patients (93.3 mg/24 h; 44.2 to 142.4); eight of the 11 non-responders had an albumin excretion above the normal range (greater than 20 mg/24 h). In the 11 patients without renal functional reserve a positive correlation was found between basal creatinine clearance and albumin excretion (r = 0.695). As consumed renal reserve and albuminuria are markers of glomerular hyperfiltration studying renal function before and after infusion of amino acids can detect hypertensive patients at risk of progressive renal damage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135009      PMCID: PMC2545951          DOI: 10.1136/bmj.296.6636.1562

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Hypertensive vascular disease; description and natural history.

Authors:  G A PERERA
Journal:  J Chronic Dis       Date:  1955-01

2.  EFFECTIVE RENAL BLOOD FLOW IN SUBJECTS WITH ESSENTIAL HYPERTENSION.

Authors:  W Goldring; H Chasis; H A Ranges; H W Smith
Journal:  J Clin Invest       Date:  1941-11       Impact factor: 14.808

3.  A solid phase fluorescent immunoassay for the measurement of human urinary albumin.

Authors:  B M Chavers; J Simonson; A F Michael
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

4.  Glomerular filtration rate following administration of individual amino acids in conscious dogs.

Authors:  K E Lee; R A Summerill
Journal:  Q J Exp Physiol       Date:  1982-07

5.  The renal vasculature in early essential hypertension: evidence for a pathogenetic role.

Authors:  N K Hollenberg; L J Borucki; D F Adams
Journal:  Medicine (Baltimore)       Date:  1978-03       Impact factor: 1.889

6.  Steroid-induced hypertension in the rat. A study of the effects of renal artery constriction on hypertension caused by deoxycorticosterone.

Authors:  R H Heptinstall; G S Hill
Journal:  Lab Invest       Date:  1967-05       Impact factor: 5.662

7.  Renal function in normo- and hypertensive 50-year-old males.

Authors:  G Berglund; M Aurell; L Wilhelmsen
Journal:  Acta Med Scand       Date:  1976

8.  Glomerular hyalinosis and its relation to hyperfiltration.

Authors:  J L Olson; A G de Urdaneta; R H Heptinstall
Journal:  Lab Invest       Date:  1985-04       Impact factor: 5.662

9.  Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate.

Authors:  J P Bosch; A Saccaggi; A Lauer; C Ronco; M Belledonne; S Glabman
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

10.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  9 in total

1.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G C Viberti; R Trevisan; R Nosadini
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 2.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

3.  Tubular proteinuria in reflux nephropathy: post ureteric re-implantation.

Authors:  C D Goonasekera; V Shah; M J Dillon
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.

Authors:  S Jalal; F A Sofi; S M Abass; M S Alai; M A Bhat; H A Rather; N A Lone; M A Siddiqi
Journal:  Indian J Nephrol       Date:  2010-01

Review 5.  Non-Traditional Risk Factors of Albuminuria in the Pediatric Population: A Scoping Review.

Authors:  Erick Sierra-Diaz; Alfredo de Jesus Celis-de la Rosa; Felipe Lozano-Kasten; Alejandro Bravo-Cuellar; Mariana Garcia-Gutierrez; Hernandez-Flores Georgina
Journal:  Int J Environ Res Public Health       Date:  2017-10-16       Impact factor: 3.390

6.  Measurement of renal functional response using iohexol clearance-a study of different outpatient procedures.

Authors:  Bjørn Steinar Lillås; Camilla Tøndel; Anna Gjerde; Bjørn Egil Vikse
Journal:  Clin Kidney J       Date:  2019-11-26

7.  A comparative evaluation of fixed dose and separately administered combinations of lisinopril and hydrochlorothiazide in treatment-naïve adult hypertensive patients in a rural Nigerian community.

Authors:  Ugochinyere Ogudu; Obiyo Nwaiwu; Olumuyiwa John Fasipe
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-08-05

8.  Prevalence and association of microalbuminuria in essential hypertensive patients.

Authors:  Bibek Poudel; Binod Kumar Yadav; Ashwini Kumar Nepal; Bharat Jha; Kanak Bahadur Raut
Journal:  N Am J Med Sci       Date:  2012-08

9.  Prevalence of Albuminuria in Children Living in a Rural Agricultural and Fishing Subsistence Community in Lake Chapala, Mexico.

Authors:  Felipe Lozano-Kasten; Erick Sierra-Diaz; Alfredo de Jesus Celis-de la Rosa; María Margarita Soto Gutiérrez; Alejandro Aarón Peregrina Lucano
Journal:  Int J Environ Res Public Health       Date:  2017-12-14       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.